An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma
Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The study proposes to evaluate the safety and efficacy of PF-03715455 in moderate to severe
asthma when added to standard of care and during staged withdrawal of background therapy.